ISRG
Intuitive Surgical, Inc. NASDAQ Listed Jun 16, 2000$453.35
Mkt Cap $160.6B
52w Low $427.84
14.5% of range
52w High $603.88
50d MA $472.29
200d MA $499.18
P/E (TTM)
57.2x
EV/EBITDA
55.0x
P/B
9.1x
Debt/Equity
0.0x
ROE
17.1%
P/FCF
81.2x
RSI (14)
—
ATR (14)
—
Beta
1.68
50d MA
$472.29
200d MA
$499.18
Avg Volume
2.0M
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System to enable complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung. It also provides a suite of stapling, energy, and core instrumentation for its surgical systems; progressive learning pathways to support the use of its technology; a complement of services to its customers, including support, installation, repair, and maintenance; and integrated digital capabilities providing unified and connected offerings, streamlining performance for hospitals with program-enhancing insights. The company was incorporated in 1995 and is headquartered in Sunnyvale, California.
1020 Kifer Road · Sunnyvale, CA 94086-5304 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 21, 2026 | AMC | 2.12 | 2.50 | +17.9% | 451.29 | +2.2% | +7.2% | +6.1% | +6.9% | +4.4% | +3.4% | — |
| Jan 22, 2026 | AMC | 2.27 | 2.53 | +11.5% | 525.81 | +0.8% | -0.3% | +0.6% | -0.1% | -0.7% | -3.5% | — |
| Oct 21, 2025 | AMC | 1.99 | 2.40 | +20.6% | 462.74 | +17.3% | +13.9% | +19.1% | +18.1% | +19.1% | +17.9% | — |
| Jul 22, 2025 | AMC | 1.93 | 2.19 | +13.5% | 511.00 | +2.3% | -1.8% | -4.4% | -3.0% | -3.3% | -2.8% | — |
| Apr 22, 2025 | AMC | 1.74 | 1.81 | +4.0% | 478.74 | +4.4% | +1.9% | +6.1% | +7.5% | +7.4% | +7.6% | — |
| Jan 23, 2025 | AMC | 1.76 | 2.21 | +25.6% | 608.66 | -4.4% | -4.0% | -5.8% | -5.7% | -5.9% | -4.7% | — |
| Oct 17, 2024 | AMC | 1.63 | 1.84 | +12.9% | 473.73 | +4.7% | +10.0% | +9.5% | +9.2% | +8.2% | +8.0% | — |
| Jul 18, 2024 | AMC | 1.54 | 1.78 | +15.6% | 416.14 | +8.0% | +9.3% | +10.8% | +9.4% | +9.1% | +5.0% | — |
| Apr 18, 2024 | AMC | 1.41 | 1.50 | +6.4% | 372.63 | +3.4% | -1.7% | -1.0% | +1.2% | +0.6% | +0.1% | — |
| Jan 23, 2024 | AMC | 1.48 | 1.60 | +8.1% | 371.41 | +3.4% | -0.4% | +1.0% | +0.9% | +2.1% | +1.6% | — |
| Oct 19, 2023 | AMC | 1.41 | 1.46 | +3.5% | 273.45 | -4.9% | -2.4% | -0.3% | +1.4% | -2.5% | -5.1% | — |
| Jul 20, 2023 | AMC | 1.33 | 1.42 | +6.8% | 347.66 | -3.4% | -3.2% | -6.9% | -4.8% | -5.3% | -6.9% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 23 | Barclays | Maintains | Overweight → Overweight | — | $483.62 | $484.50 | +0.2% | -1.0% | -0.3% | -2.6% | -3.5% | -6.2% |
| Apr 22 | Piper Sandler | Maintains | Overweight → Overweight | — | $451.29 | $461.36 | +2.2% | +7.2% | +6.1% | +6.9% | +4.4% | +3.4% |
| Apr 22 | Leerink Partners | Maintains | Outperform → Outperform | — | $451.29 | $461.36 | +2.2% | +7.2% | +6.1% | +6.9% | +4.4% | +3.4% |
| Apr 22 | Baird | Maintains | Outperform → Outperform | — | $451.29 | $461.36 | +2.2% | +7.2% | +6.1% | +6.9% | +4.4% | +3.4% |
| Apr 22 | BTIG | Maintains | Buy → Buy | — | $451.29 | $461.36 | +2.2% | +7.2% | +6.1% | +6.9% | +4.4% | +3.4% |
| Apr 15 | Truist | Maintains | Buy → Buy | — | $467.22 | $469.55 | +0.5% | +0.2% | -2.0% | +0.4% | -0.3% | -3.4% |
| Apr 13 | Mizuho | Maintains | Neutral → Neutral | — | $450.62 | $448.17 | -0.5% | +1.9% | +3.7% | +3.9% | +1.7% | +4.1% |
| Apr 10 | BTIG | Maintains | Buy → Buy | — | $454.94 | $455.69 | +0.2% | -0.9% | +0.9% | +2.7% | +2.9% | +0.7% |
| Apr 9 | Goldman Sachs | Maintains | Buy → Buy | — | $462.28 | $459.32 | -0.6% | -1.6% | -2.5% | -0.7% | +1.1% | +1.3% |
| Apr 6 | Evercore ISI | Maintains | In Line → In Line | — | $452.07 | $451.06 | -0.2% | +0.1% | +0.2% | +2.3% | +0.6% | -0.3% |
| Mar 17 | UBS | Maintains | Neutral → Neutral | — | $483.46 | $487.54 | +0.8% | -0.1% | -1.2% | -0.7% | -1.1% | -1.1% |
| Mar 11 | Citigroup | Upgrade | Neutral → Buy | — | $485.85 | $489.23 | +0.7% | +1.4% | -1.4% | -2.8% | -0.5% | -0.6% |
| Feb 24 | UBS | Maintains | Neutral → Neutral | — | $492.10 | $489.69 | -0.5% | +0.4% | +2.9% | +3.0% | +2.3% | +0.8% |
| Jan 27 | Freedom Capital Markets | Upgrade | Hold → Buy | — | $528.81 | $532.61 | +0.7% | -0.7% | -1.3% | -4.0% | -4.7% | -6.1% |
| Jan 26 | Barclays | Maintains | Overweight → Overweight | — | $523.99 | $523.95 | -0.0% | +0.9% | +0.2% | -0.4% | -3.1% | -3.8% |
| Jan 26 | Freedom Broker | Upgrade | Hold → Buy | — | $523.99 | $523.95 | -0.0% | +0.9% | +0.2% | -0.4% | -3.1% | -3.8% |
| Jan 23 | Bernstein | Maintains | Outperform → Outperform | — | $525.81 | $530.00 | +0.8% | -0.3% | +0.6% | -0.1% | -0.7% | -3.5% |
| Jan 23 | Evercore ISI | Maintains | In Line → In Line | — | $525.81 | $530.00 | +0.8% | -0.3% | +0.6% | -0.1% | -0.7% | -3.5% |
| Jan 23 | Piper Sandler | Maintains | Overweight → Overweight | — | $525.81 | $530.00 | +0.8% | -0.3% | +0.6% | -0.1% | -0.7% | -3.5% |
| Jan 23 | BTIG | Maintains | Buy → Buy | — | $525.81 | $530.00 | +0.8% | -0.3% | +0.6% | -0.1% | -0.7% | -3.5% |
| Jan 23 | Citigroup | Maintains | Neutral → Neutral | — | $525.81 | $530.00 | +0.8% | -0.3% | +0.6% | -0.1% | -0.7% | -3.5% |
| Jan 9 | Bernstein | Maintains | Outperform → Outperform | — | $585.08 | $587.32 | +0.4% | +0.2% | -2.1% | -4.0% | -6.5% | -7.5% |
| Jan 7 | BTIG | Maintains | Buy → Buy | — | $592.85 | $592.89 | +0.0% | -0.1% | -1.3% | -1.1% | -3.4% | -5.2% |
| Jan 7 | Barclays | Maintains | Overweight → Overweight | — | $592.85 | $592.89 | +0.0% | -0.1% | -1.3% | -1.1% | -3.4% | -5.2% |
| Dec 18 | Truist | Maintains | Buy → Buy | — | $556.86 | $557.29 | +0.1% | +0.9% | +2.8% | +4.1% | +3.7% | +3.6% |
| Dec 17 | RBC Capital | Maintains | Outperform → Outperform | — | $554.58 | $554.68 | +0.0% | +0.4% | +1.3% | +3.2% | +4.6% | +4.1% |
| Dec 11 | Citigroup | Downgrade | Buy → Neutral | — | $555.92 | $545.47 | -1.9% | -1.5% | -2.4% | +0.6% | -0.2% | +0.2% |
| Oct 28 | Freedom Broker | Maintains | Buy → Buy | — | $551.25 | $546.62 | -0.8% | -1.1% | -2.5% | -3.9% | -3.1% | -1.3% |
| Oct 23 | UBS | Maintains | Neutral → Neutral | — | $527.03 | $525.37 | -0.3% | +4.6% | +3.7% | +4.6% | +3.5% | +2.0% |
| Oct 22 | Truist | Maintains | Buy → Buy | — | $462.74 | $543.00 | +17.3% | +13.9% | +19.1% | +18.1% | +19.1% | +17.9% |
| Oct 22 | Piper Sandler | Maintains | Overweight → Overweight | — | $462.74 | $543.00 | +17.3% | +13.9% | +19.1% | +18.1% | +19.1% | +17.9% |
| Oct 22 | Raymond James | Maintains | Outperform → Outperform | — | $462.74 | $543.00 | +17.3% | +13.9% | +19.1% | +18.1% | +19.1% | +17.9% |
| Oct 22 | Wells Fargo | Maintains | Overweight → Overweight | — | $462.74 | $543.00 | +17.3% | +13.9% | +19.1% | +18.1% | +19.1% | +17.9% |
| Oct 22 | RBC Capital | Maintains | Outperform → Outperform | — | $462.74 | $543.00 | +17.3% | +13.9% | +19.1% | +18.1% | +19.1% | +17.9% |
| Oct 22 | BTIG | Maintains | Buy → Buy | — | $462.74 | $543.00 | +17.3% | +13.9% | +19.1% | +18.1% | +19.1% | +17.9% |
| Oct 15 | Truist | Maintains | Buy → Buy | — | $436.39 | $437.00 | +0.1% | -0.2% | -0.4% | +2.2% | +5.1% | +6.0% |
| Oct 13 | BTIG | Maintains | Buy → Buy | — | $429.59 | $432.43 | +0.7% | +1.4% | +1.6% | +1.4% | +1.2% | +3.9% |
| Oct 7 | Evercore ISI | Maintains | In Line → In Line | — | $449.69 | $449.24 | -0.1% | -1.9% | -0.4% | -1.3% | -4.5% | -3.1% |
| Oct 1 | BTIG | Maintains | Buy → Buy | — | $447.23 | $447.00 | -0.1% | -2.1% | -0.9% | +1.1% | +0.6% | -1.4% |
| Aug 19 | RBC Capital | Maintains | Outperform → Outperform | — | $481.28 | $480.99 | -0.1% | -0.4% | -0.2% | -2.4% | -1.1% | -2.7% |
| Jul 23 | Truist | Maintains | Buy → Buy | — | $511.00 | $522.50 | +2.3% | -1.8% | -4.4% | -3.0% | -3.3% | -2.8% |
| Jul 23 | UBS | Maintains | Neutral → Neutral | — | $511.00 | $522.50 | +2.3% | -1.8% | -4.4% | -3.0% | -3.3% | -2.8% |
| Jul 23 | Piper Sandler | Maintains | Overweight → Overweight | — | $511.00 | $522.50 | +2.3% | -1.8% | -4.4% | -3.0% | -3.3% | -2.8% |
| Jul 23 | BTIG | Maintains | Buy → Buy | — | $511.00 | $522.50 | +2.3% | -1.8% | -4.4% | -3.0% | -3.3% | -2.8% |
| Jul 23 | Wells Fargo | Maintains | Overweight → Overweight | — | $511.00 | $522.50 | +2.3% | -1.8% | -4.4% | -3.0% | -3.3% | -2.8% |
| Jul 23 | RBC Capital | Maintains | Outperform → Outperform | — | $511.00 | $522.50 | +2.3% | -1.8% | -4.4% | -3.0% | -3.3% | -2.8% |
| Jul 8 | Evercore ISI | Maintains | In Line → In Line | — | $534.71 | $534.00 | -0.1% | -1.4% | -1.2% | -1.6% | -4.2% | -3.4% |
| Jun 9 | Deutsche Bank | Downgrade | Hold → Sell | — | $557.08 | $531.50 | -4.6% | -5.6% | -4.9% | -6.2% | -7.9% | -8.1% |
| May 22 | Citigroup | Maintains | Buy → Buy | — | $547.07 | $544.81 | -0.4% | -0.8% | -1.4% | +0.6% | +1.0% | +1.6% |
| Apr 24 | Barclays | Maintains | Overweight → Overweight | — | $487.93 | $490.82 | +0.6% | +4.1% | +5.5% | +5.3% | +5.5% | +5.7% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| Apr 29, 2026 | Ladd Amy LDir | — | Sell | 119 | $463.50 | $55K | 120 | +0.83% | -0.46% |
| Apr 28, 2026 | Ladd Amy LDir | — | Sell | 500 | $473.46 | $237K | 239 | +0.83% | -0.46% |
8-K
Intuitive Surgical Inc. -- 8-K Filing
Intuitive Surgical's Q1 2026 worldwide procedures grew 17% year-over-year across its da Vinci and Ion platforms, demonstrating strong demand for its robotic-assisted surgery systems.
Apr 21
8-K · 7.01
! Medium
Unknown — 8-K 7.01: Regulation FD Disclosure
Accuray's appointment of an experienced Chief Commercial Officer signals management's confidence in accelerating sales growth and market expansion, which could drive revenue acceleration and improve investor sentiment if execution succeeds.
Apr 6
8-K · 8.01
!! High
Intel Corp -- 8-K 8.01: Material Event / Announcement
Intel's board will shrink to eleven directors after its 2026 annual meeting, reflecting organizational streamlining that may signal cost-reduction efforts amid the chipmaker's strategic transition.
Mar 3
8-K
Intuitive Surgical Inc. -- 8-K Filing
Intuitive Surgical (ISRG) completed its acquisition of da Vinci and Ion distribution operations in Southern Europe, directly expanding its surgical robotics market presence across Italy, Spain, Portugal, and Malta.
Mar 2
8-K · 1.01
!! High
UFP Technologies Inc -- 8-K 1.01: Supply Agreement
UFP Technologies secured an amended supply agreement with Intuitive Surgical, a key strategic customer, potentially strengthening revenue visibility and the long-term partnership in medical device manufacturing.
Feb 24
Data updated apr 25, 2026 4:21pm
· Source: massive.com